http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8
.trig | .trig.txt | .jelly | .jelly.txt
@prefix dc1: <http://purl.org/dc/terms/> . @prefix this: <http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8> . @prefix sub: <http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#> . @prefix schema: <https://schema.org/> . @prefix np: <http://www.nanopub.org/nschema#> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix nt: <https://w3id.org/np/o/ntemplate/> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix orcid: <https://orcid.org/> . @prefix bl: <https://w3id.org/biolink/vocab/> . @prefix prov: <http://www.w3.org/ns/prov#> . @prefix npx: <http://purl.org/nanopub/x/> . sub:Head { this: a np:Nanopublication; np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo . } sub:assertion { <http://purl.obolibrary.org/obo/DOID_13146> bl:category bl:Disease . sub:association a rdf:Statement; rdf:object <http://purl.obolibrary.org/obo/DOID_13146>; rdf:predicate bl:treats; rdf:subject <https://identifiers.org/drugbank:DB00520>; rdfs:label "caspofungin acetate is an echinocandin antifungal indicated in adults and pediatric patients 3 months of age and older for empirical therapy for presumed fungal infections in febrile neutropenic patients 1 treatment of candidemia and the following candida 1 treatment of esophageal candidiasis 1 treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies 1 caspofungin acetate for injection is indicated as empirical therapy for presumed fungal infections in febrile neutropenic adult and pediatric patients 3 months of age and older see clinical studies 14 1 14 5 caspofungin acetate for injection is indicated for the treatment of candidemia and the following candida infections intra abdominal abscesses peritonitis and pleural space infections in adult and pediatric patients 3 months of age and older see clinical studies 14 2 14 5 limitations of use candida caspofungin acetate for injection is indicated for the treatment of esophageal candidiasis in adult and pediatric patients 3 months of age and older see clinical studies 14 3 14 5 limitations of use see clinical studies 14 3 caspofungin acetate for injection is indicated for the treatment of invasive aspergillosis in adult and pediatric patients 3 months of age and older who are refractory to or intolerant of other therapies see clinical studies 14 4 14 5 limitations of use"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by <https://w3id.org/um/NeuroDKG>; bl:relation schema:TreatmentIndication . <https://identifiers.org/drugbank:DB00520> bl:category bl:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "WJSKHDkHvF5pI97AfODVSSuuoGGHmcj2X/YcTrOd6TLd7UWKy9WpFxSyV64oEh/6mYGoGyos22dI16+E5ATJIqxAUlNfc+EtY6HCtf3Nr3/zwojqrF/mrMtaCKRVfQqLemynRYmGvwc93KMezAM/ezGRE5aAV8wLUImYA6MjGVE="; npx:hasSignatureTarget this: . this: dc1:created "2021-06-13T16:37:05.692+02:00"^^xsd:dateTime; dc1:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>; nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>; nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> . }